Status unknownNCT03397459CNSBS-NCBESUpdated Jan 12, 2018

Cervicobrachial Neuralgia and Sagital Balance of the Cervical Spine

An observational study in Cervicobrachial Neuralgia and Lordosis, sponsored by Centre Hospitalier Universitaire de Besancon. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-01-12.

Sponsored by Centre Hospitalier Universitaire de Besancon · Observational

The sponsor has not verified this record recently (last verified Dec 2017), so the status shown — last known as Recruiting — may be out of date.

Study type: Observational
Model: Cohort
Time perspective: Prospective
Enrollment: 132
Ages: 18 Years and older
Sex: All

Study summary

The aim of this observational study is to establish estimation of global lordosis of the cervical spine (from C3 to C7) in patients with cervicobrachial neuralgia.

Read the detailed description

The main judgement critearia is the estimation in degree of this lordosis measured on EOS radiographies, The study includes adults patients with non traumatic cervicobrachial neuralgia caused by discal hernia free from any previous spine surgery.

Conditions studied

Cervicobrachial Neuralgia
Lordosis

Browse trials for

Lordosis 30

Keywords

cervicobrachial neuralgia
sagittal balance
lordosis

In context

Lordosis

30 studies on the registry are indexed under Lordosis; 5 are open to participants now.

This study's planned enrollment of 132 is above the median of 59 across 14 observational studies indexed under Lordosis.

Browse Lordosis studies →

Lead sponsor

Centre Hospitalier Universitaire de Besancon is the lead sponsor of 450 studies on the registry; 97 are open to participants now.

Browse Centre Hospitalier Universitaire de Besancon studies →

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years and older
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

Patients suffering of cervicobrachial neuralgia in the hospital of BESANCON, FRANCE followed by a neurosurgeon.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Adults (>18 years old)
Suffering of cervicobrachial neuralgia caused by cervical hernia on MRI diagnosed by a neurosurgeon
with social care rights

Exclusion criteria

Exclusion Criteria:

Post traumatic cervicobrachial neuralgia in the past 12 months
Anteriority of spine surgery
Pregnant patients

Study design

Observational model: Cohort
Time perspective: Prospective
Enrollment: 132 participants (estimated)
Patient registry: No

Interventions

Diagnostic testSpine teleradiography EOS

What researchers measure

Primary outcomes

Low Cervical spine lordosis
In degree, the angle between the lower plate of C2 and the lower plate of the last cervical vertebrea (physiologycally)
Time frame: Day 1

Secondary outcomes

NDI
Pain questionnaires (score of 0 and 50)
Time frame: Day 1

Study locations

1 of 1 sites recruiting

HAMDAN
Besancon, 25000, France
Recruiting
- Noor HAMDAN · Contact
Recruiting

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Timeline

Tracking since Sep 25, 2026

ElapsedEstimatedEstimated, not yet reached

Started Jan 2015 (actual). Primary completion is estimated for Dec 2018, 47 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered: Dec 21, 2017
First posted: Jan 12, 2018
StartActual: Jan 1, 2015
Primary completionEst.: Dec 31, 2018
CompletionEst.: Dec 31, 2018
Last update: Jan 12, 2018

What these dates mean

Start.: When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.: When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.: When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.: Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.

No changes since tracking began. The registry record was last updated on Jan 12, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT03397459
Lead sponsor: Centre Hospitalier Universitaire de Besancon
Responsible party: Sponsor
First posted: Jan 12, 2018
Start date: Jan 1, 2015
Primary completion: Dec 31, 2018 (estimated)
Completion: Dec 31, 2018 (estimated)
Last update: Jan 12, 2018

Study contacts

Noor HAMDAN

Contact

hmdnnoor@gmail.com

Oversight

Data monitoring committee: Yes
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Lordosis →

Other studies from this sponsor

Centre Hospitalier Universitaire de Besancon →

Start the discussion